| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Mucosa | 21 | 2026 | 68 | 3.650 |
Why?
|
| Cell Differentiation | 16 | 2026 | 427 | 3.440 |
Why?
|
| Epithelial Cells | 17 | 2026 | 265 | 2.810 |
Why?
|
| Bronchi | 6 | 2021 | 38 | 2.160 |
Why?
|
| Receptor, Notch3 | 4 | 2022 | 15 | 1.710 |
Why?
|
| Endothelial Cells | 6 | 2025 | 373 | 1.240 |
Why?
|
| Viral Proteins | 8 | 2010 | 63 | 1.170 |
Why?
|
| Smoking | 8 | 2017 | 477 | 1.160 |
Why?
|
| Herpesvirus 3, Human | 6 | 2010 | 12 | 1.160 |
Why?
|
| Lung | 6 | 2023 | 382 | 1.130 |
Why?
|
| Receptors, Notch | 3 | 2022 | 44 | 1.130 |
Why?
|
| Epithelium | 3 | 2017 | 40 | 1.120 |
Why?
|
| Smoke | 2 | 2021 | 37 | 1.100 |
Why?
|
| Signal Transduction | 11 | 2025 | 1469 | 1.030 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 4 | 2021 | 68 | 1.030 |
Why?
|
| Cigarette Smoking | 3 | 2021 | 82 | 0.880 |
Why?
|
| Cells, Cultured | 16 | 2026 | 1022 | 0.840 |
Why?
|
| Lung Diseases | 2 | 2022 | 43 | 0.840 |
Why?
|
| Immediate-Early Proteins | 6 | 2010 | 15 | 0.810 |
Why?
|
| Humans | 53 | 2026 | 28851 | 0.810 |
Why?
|
| Immunity, Innate | 2 | 2025 | 231 | 0.790 |
Why?
|
| Biological Phenomena | 1 | 2022 | 4 | 0.770 |
Why?
|
| Cell Proliferation | 5 | 2021 | 824 | 0.740 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2021 | 53 | 0.690 |
Why?
|
| Goblet Cells | 1 | 2021 | 15 | 0.690 |
Why?
|
| Repressor Proteins | 1 | 2021 | 119 | 0.670 |
Why?
|
| Tobacco Products | 2 | 2021 | 205 | 0.670 |
Why?
|
| Histone Deacetylase 2 | 2 | 2010 | 10 | 0.650 |
Why?
|
| Basement Membrane | 2 | 2017 | 6 | 0.600 |
Why?
|
| Dendritic Cells, Follicular | 1 | 2018 | 1 | 0.600 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 1 | 2018 | 1 | 0.600 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2018 | 6 | 0.590 |
Why?
|
| Paraneoplastic Syndromes | 1 | 2018 | 9 | 0.590 |
Why?
|
| Cellular Senescence | 2 | 2021 | 141 | 0.560 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 148 | 0.560 |
Why?
|
| Paracrine Communication | 2 | 2015 | 17 | 0.550 |
Why?
|
| Gene Expression Profiling | 8 | 2018 | 465 | 0.550 |
Why?
|
| Herpesvirus 2, Saimiriine | 4 | 2005 | 4 | 0.550 |
Why?
|
| Autoimmune Diseases | 1 | 2018 | 166 | 0.520 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 285 | 0.520 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2017 | 41 | 0.510 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 6 | 0.500 |
Why?
|
| Virus Replication | 4 | 2025 | 66 | 0.490 |
Why?
|
| Receptor, Insulin | 1 | 2017 | 93 | 0.490 |
Why?
|
| Transcriptional Activation | 3 | 2005 | 86 | 0.490 |
Why?
|
| Hyperoxia | 3 | 2026 | 95 | 0.470 |
Why?
|
| Matrix Metalloproteinase 14 | 1 | 2015 | 3 | 0.470 |
Why?
|
| Receptor, Notch1 | 1 | 2015 | 27 | 0.450 |
Why?
|
| Cell Culture Techniques | 2 | 2024 | 117 | 0.440 |
Why?
|
| Cilia | 4 | 2017 | 42 | 0.440 |
Why?
|
| Male | 18 | 2021 | 13921 | 0.440 |
Why?
|
| Adult | 14 | 2021 | 8024 | 0.440 |
Why?
|
| Trans-Activators | 4 | 2016 | 118 | 0.430 |
Why?
|
| Stem Cells | 4 | 2016 | 123 | 0.430 |
Why?
|
| Multipotent Stem Cells | 1 | 2013 | 5 | 0.420 |
Why?
|
| Cell Line | 9 | 2020 | 700 | 0.410 |
Why?
|
| Stroke | 4 | 2022 | 260 | 0.410 |
Why?
|
| Promoter Regions, Genetic | 3 | 2005 | 344 | 0.400 |
Why?
|
| Transcriptome | 3 | 2021 | 231 | 0.390 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2010 | 72 | 0.390 |
Why?
|
| Gene Expression Regulation | 6 | 2021 | 634 | 0.390 |
Why?
|
| Female | 17 | 2021 | 15624 | 0.380 |
Why?
|
| Herpes Zoster | 2 | 2009 | 20 | 0.380 |
Why?
|
| Case-Control Studies | 7 | 2021 | 739 | 0.370 |
Why?
|
| Middle Aged | 12 | 2021 | 7414 | 0.370 |
Why?
|
| Mitochondria | 2 | 2026 | 408 | 0.370 |
Why?
|
| Viral Envelope Proteins | 2 | 2010 | 6 | 0.370 |
Why?
|
| Aged | 7 | 2021 | 5598 | 0.360 |
Why?
|
| Cell Nucleus | 2 | 2010 | 138 | 0.350 |
Why?
|
| Antigens, Nuclear | 2 | 2010 | 22 | 0.340 |
Why?
|
| Genome, Viral | 3 | 2019 | 34 | 0.340 |
Why?
|
| Alphaherpesvirinae | 1 | 2010 | 1 | 0.330 |
Why?
|
| Interferons | 2 | 2021 | 70 | 0.330 |
Why?
|
| RING Finger Domains | 1 | 2010 | 1 | 0.330 |
Why?
|
| Animals | 12 | 2025 | 10684 | 0.320 |
Why?
|
| Histone Deacetylase 1 | 1 | 2009 | 10 | 0.310 |
Why?
|
| Autoantigens | 2 | 2010 | 212 | 0.310 |
Why?
|
| Geminiviridae | 3 | 2019 | 3 | 0.310 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2021 | 63 | 0.310 |
Why?
|
| Molecular Sequence Data | 6 | 2012 | 1056 | 0.290 |
Why?
|
| Amino Acid Sequence | 5 | 2010 | 697 | 0.270 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 328 | 0.260 |
Why?
|
| Genetic Variation | 3 | 2017 | 245 | 0.260 |
Why?
|
| Plant Diseases | 2 | 2017 | 39 | 0.260 |
Why?
|
| Recombination, Genetic | 3 | 2013 | 64 | 0.260 |
Why?
|
| RNA Interference | 2 | 2017 | 137 | 0.250 |
Why?
|
| Coculture Techniques | 2 | 2017 | 55 | 0.250 |
Why?
|
| Brain Ischemia | 2 | 2018 | 87 | 0.240 |
Why?
|
| Sulfurtransferases | 1 | 2026 | 11 | 0.240 |
Why?
|
| Neurons | 1 | 2008 | 297 | 0.240 |
Why?
|
| Phosphatidylethanolamine Binding Protein | 1 | 2025 | 2 | 0.240 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2025 | 35 | 0.230 |
Why?
|
| Response Elements | 2 | 2005 | 22 | 0.230 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2025 | 28 | 0.230 |
Why?
|
| Tetraspanins | 1 | 2025 | 54 | 0.230 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2025 | 65 | 0.220 |
Why?
|
| Capillary Permeability | 1 | 2025 | 56 | 0.220 |
Why?
|
| Receptors, Steroid | 1 | 2025 | 26 | 0.220 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 351 | 0.220 |
Why?
|
| AT-Hook Motifs | 1 | 2004 | 1 | 0.220 |
Why?
|
| Phosphorylation | 4 | 2025 | 585 | 0.220 |
Why?
|
| Antiviral Agents | 1 | 2025 | 114 | 0.210 |
Why?
|
| Heat-Shock Proteins | 1 | 2004 | 38 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 2 | 2014 | 35 | 0.210 |
Why?
|
| Cholesterol | 1 | 2025 | 203 | 0.210 |
Why?
|
| Proteomics | 1 | 2025 | 197 | 0.210 |
Why?
|
| Ischemic Attack, Transient | 1 | 2024 | 26 | 0.210 |
Why?
|
| Carotid Intima-Media Thickness | 2 | 2020 | 12 | 0.210 |
Why?
|
| Deubiquitinating Enzymes | 1 | 2023 | 6 | 0.210 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2023 | 14 | 0.200 |
Why?
|
| Cell Membrane | 1 | 2025 | 268 | 0.200 |
Why?
|
| DNA, Viral | 5 | 2019 | 63 | 0.200 |
Why?
|
| Papio | 1 | 2023 | 81 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 2 | 2021 | 95 | 0.190 |
Why?
|
| DNA Methylation | 4 | 2017 | 152 | 0.190 |
Why?
|
| Mammals | 1 | 2022 | 48 | 0.190 |
Why?
|
| Adolescent | 3 | 2018 | 3193 | 0.180 |
Why?
|
| Young Adult | 6 | 2019 | 2833 | 0.180 |
Why?
|
| Air | 1 | 2021 | 23 | 0.180 |
Why?
|
| Tissue Donors | 1 | 2021 | 25 | 0.180 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 28 | 0.170 |
Why?
|
| Cell Death | 1 | 2021 | 119 | 0.170 |
Why?
|
| Hypertension | 1 | 2024 | 309 | 0.170 |
Why?
|
| White Matter | 1 | 2022 | 90 | 0.170 |
Why?
|
| Trachea | 3 | 2026 | 43 | 0.170 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 485 | 0.170 |
Why?
|
| RNA, Small Interfering | 1 | 2021 | 198 | 0.170 |
Why?
|
| Carotid Artery, Common | 1 | 2020 | 11 | 0.160 |
Why?
|
| Risk Factors | 3 | 2024 | 2126 | 0.160 |
Why?
|
| Interferon Regulatory Factor-7 | 1 | 2020 | 7 | 0.160 |
Why?
|
| Extracellular Vesicles | 1 | 2021 | 53 | 0.160 |
Why?
|
| Smokers | 1 | 2021 | 128 | 0.160 |
Why?
|
| Bacterial Proteins | 1 | 2004 | 497 | 0.160 |
Why?
|
| Phylogeography | 2 | 2017 | 17 | 0.160 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 465 | 0.160 |
Why?
|
| Influenza A virus | 1 | 2020 | 37 | 0.160 |
Why?
|
| Simuliidae | 1 | 2019 | 1 | 0.150 |
Why?
|
| DNA Viruses | 1 | 2019 | 4 | 0.150 |
Why?
|
| DNA, Single-Stranded | 1 | 2019 | 9 | 0.150 |
Why?
|
| Genome, Human | 2 | 2017 | 70 | 0.150 |
Why?
|
| Atherosclerosis | 1 | 2020 | 97 | 0.150 |
Why?
|
| Up-Regulation | 2 | 2017 | 247 | 0.150 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 62 | 0.150 |
Why?
|
| Cytokines | 1 | 2021 | 451 | 0.150 |
Why?
|
| Endothelial Protein C Receptor | 1 | 2018 | 7 | 0.150 |
Why?
|
| Influenza, Human | 1 | 2020 | 92 | 0.150 |
Why?
|
| Thrombomodulin | 1 | 2018 | 11 | 0.150 |
Why?
|
| Age of Onset | 2 | 2018 | 72 | 0.140 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2018 | 555 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 118 | 0.140 |
Why?
|
| Biopsy | 1 | 2018 | 208 | 0.140 |
Why?
|
| Open Reading Frames | 3 | 2019 | 39 | 0.140 |
Why?
|
| Infant, Newborn | 3 | 2026 | 916 | 0.140 |
Why?
|
| Biomarkers | 3 | 2020 | 776 | 0.140 |
Why?
|
| Host Specificity | 1 | 2017 | 2 | 0.130 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 379 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2016 | 515 | 0.130 |
Why?
|
| Poaceae | 1 | 2017 | 26 | 0.130 |
Why?
|
| Oryza | 1 | 2017 | 42 | 0.130 |
Why?
|
| Time Factors | 1 | 2021 | 1613 | 0.130 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 2016 | 2 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 35 | 0.130 |
Why?
|
| Gene Deletion | 2 | 2009 | 120 | 0.130 |
Why?
|
| Autophagy | 1 | 2017 | 77 | 0.130 |
Why?
|
| Inflammation | 1 | 2021 | 667 | 0.130 |
Why?
|
| Down-Regulation | 1 | 2017 | 202 | 0.130 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2021 | 179 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 114 | 0.120 |
Why?
|
| Prognosis | 1 | 2018 | 811 | 0.120 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 87 | 0.120 |
Why?
|
| RNA | 1 | 2017 | 111 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 58 | 0.120 |
Why?
|
| Immunity | 1 | 2016 | 27 | 0.120 |
Why?
|
| Muscle Weakness | 1 | 2015 | 16 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2013 | 490 | 0.120 |
Why?
|
| Stroke Rehabilitation | 1 | 2015 | 14 | 0.120 |
Why?
|
| Patient Safety | 1 | 2015 | 38 | 0.120 |
Why?
|
| Fibroblast Growth Factor 5 | 1 | 2015 | 1 | 0.120 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2015 | 10 | 0.120 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2015 | 29 | 0.120 |
Why?
|
| Biomarkers, Tumor | 1 | 2018 | 415 | 0.120 |
Why?
|
| Bronchopulmonary Dysplasia | 2 | 2026 | 63 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2018 | 676 | 0.120 |
Why?
|
| Cell Line, Transformed | 2 | 2021 | 42 | 0.120 |
Why?
|
| Fibroblast Growth Factors | 1 | 2015 | 26 | 0.110 |
Why?
|
| DNA | 1 | 2017 | 377 | 0.110 |
Why?
|
| Secretory Pathway | 1 | 2015 | 6 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 62 | 0.110 |
Why?
|
| SOS1 Protein | 1 | 2014 | 3 | 0.110 |
Why?
|
| Metabolomics | 1 | 2016 | 87 | 0.110 |
Why?
|
| Ciliary Motility Disorders | 1 | 2014 | 2 | 0.110 |
Why?
|
| Proteins | 1 | 2017 | 254 | 0.110 |
Why?
|
| Telomere Shortening | 1 | 2014 | 4 | 0.110 |
Why?
|
| Ligands | 1 | 2015 | 178 | 0.110 |
Why?
|
| Vagus Nerve Stimulation | 1 | 2015 | 76 | 0.110 |
Why?
|
| ras Proteins | 1 | 2014 | 43 | 0.110 |
Why?
|
| Matrix Metalloproteinase 12 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Tight Junctions | 1 | 2014 | 29 | 0.110 |
Why?
|
| Phenotype | 2 | 2013 | 685 | 0.110 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 117 | 0.110 |
Why?
|
| Telomere | 1 | 2014 | 36 | 0.110 |
Why?
|
| Dual Specificity Phosphatase 6 | 1 | 2014 | 3 | 0.110 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 284 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 114 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2014 | 8 | 0.110 |
Why?
|
| Retroviridae | 1 | 2013 | 16 | 0.100 |
Why?
|
| DNA Primers | 2 | 2012 | 147 | 0.100 |
Why?
|
| Genetic Loci | 1 | 2014 | 77 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 123 | 0.100 |
Why?
|
| Telomerase | 1 | 2013 | 38 | 0.100 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 376 | 0.100 |
Why?
|
| Aging | 1 | 2021 | 1016 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 2065 | 0.100 |
Why?
|
| Psittaciformes | 1 | 2013 | 3 | 0.100 |
Why?
|
| Circovirus | 1 | 2013 | 5 | 0.100 |
Why?
|
| Circoviridae Infections | 1 | 2013 | 5 | 0.100 |
Why?
|
| Bird Diseases | 1 | 2013 | 14 | 0.100 |
Why?
|
| Transfection | 1 | 2013 | 319 | 0.100 |
Why?
|
| Receptor Cross-Talk | 1 | 2012 | 11 | 0.090 |
Why?
|
| RNA, Messenger | 1 | 2014 | 668 | 0.090 |
Why?
|
| Reassortant Viruses | 1 | 2012 | 2 | 0.090 |
Why?
|
| Babuvirus | 1 | 2012 | 3 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2013 | 523 | 0.090 |
Why?
|
| Coronary Artery Disease | 1 | 2014 | 220 | 0.090 |
Why?
|
| Respiratory System | 1 | 2011 | 13 | 0.090 |
Why?
|
| Liver | 1 | 2014 | 471 | 0.080 |
Why?
|
| Herpesvirus 1, Suid | 1 | 2010 | 2 | 0.080 |
Why?
|
| Genes, Viral | 1 | 2010 | 10 | 0.080 |
Why?
|
| Vero Cells | 1 | 2010 | 12 | 0.080 |
Why?
|
| Virus Latency | 2 | 2008 | 9 | 0.080 |
Why?
|
| Herpesvirus 1, Human | 1 | 2010 | 24 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 133 | 0.080 |
Why?
|
| Protein Stability | 1 | 2010 | 43 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 104 | 0.080 |
Why?
|
| Simplexvirus | 1 | 2009 | 5 | 0.080 |
Why?
|
| Mutation | 2 | 2010 | 867 | 0.080 |
Why?
|
| Phylogeny | 3 | 2017 | 490 | 0.080 |
Why?
|
| Base Sequence | 1 | 2010 | 588 | 0.080 |
Why?
|
| Genetic Vectors | 1 | 2009 | 118 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2009 | 1350 | 0.070 |
Why?
|
| Luciferases, Renilla | 1 | 2008 | 1 | 0.070 |
Why?
|
| Cell Transformation, Viral | 1 | 2008 | 7 | 0.070 |
Why?
|
| Genome-Wide Association Study | 3 | 2014 | 237 | 0.070 |
Why?
|
| Subcellular Fractions | 1 | 2008 | 22 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2008 | 17 | 0.070 |
Why?
|
| Ganglia | 1 | 2008 | 9 | 0.070 |
Why?
|
| Glutathione Transferase | 1 | 2008 | 33 | 0.070 |
Why?
|
| Enteric Nervous System | 1 | 2008 | 10 | 0.070 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2008 | 50 | 0.070 |
Why?
|
| Guinea Pigs | 1 | 2008 | 73 | 0.070 |
Why?
|
| Protein Kinases | 1 | 2009 | 155 | 0.070 |
Why?
|
| Adenoviridae | 1 | 2008 | 68 | 0.070 |
Why?
|
| Plasmids | 1 | 2008 | 126 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 699 | 0.070 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2008 | 80 | 0.070 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 233 | 0.070 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2004 | 12 | 0.060 |
Why?
|
| Protein Binding | 2 | 2025 | 667 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2005 | 1 | 0.060 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 4 | 0.060 |
Why?
|
| Tars | 1 | 2005 | 5 | 0.060 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2025 | 16 | 0.060 |
Why?
|
| Virus Activation | 2 | 2005 | 9 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2025 | 25 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2025 | 33 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2005 | 6 | 0.060 |
Why?
|
| Simvastatin | 1 | 2025 | 24 | 0.060 |
Why?
|
| Muscle, Smooth | 1 | 2005 | 41 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2005 | 45 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2005 | 39 | 0.060 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2025 | 45 | 0.060 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2025 | 77 | 0.060 |
Why?
|
| Protein Conformation | 1 | 2025 | 258 | 0.060 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2025 | 128 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2024 | 2 | 0.050 |
Why?
|
| Allopurinol | 1 | 2024 | 2 | 0.050 |
Why?
|
| Uric Acid | 1 | 2024 | 7 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2004 | 132 | 0.050 |
Why?
|
| Cluster Analysis | 2 | 2016 | 126 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 194 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2024 | 357 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2025 | 874 | 0.050 |
Why?
|
| Oxidative Stress | 2 | 2017 | 677 | 0.050 |
Why?
|
| Neuroimaging | 1 | 2022 | 88 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2021 | 56 | 0.040 |
Why?
|
| Emotions | 1 | 2022 | 137 | 0.040 |
Why?
|
| Pulse Wave Analysis | 1 | 2020 | 30 | 0.040 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2020 | 15 | 0.040 |
Why?
|
| Airway Remodeling | 1 | 2019 | 1 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2020 | 134 | 0.040 |
Why?
|
| Microviridae | 1 | 2019 | 1 | 0.040 |
Why?
|
| New Zealand | 1 | 2019 | 12 | 0.040 |
Why?
|
| Chiroptera | 1 | 2019 | 10 | 0.040 |
Why?
|
| Viruses | 1 | 2019 | 20 | 0.040 |
Why?
|
| Research Design | 1 | 2020 | 187 | 0.040 |
Why?
|
| Metagenomics | 1 | 2019 | 57 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2018 | 51 | 0.040 |
Why?
|
| Feces | 1 | 2019 | 116 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 242 | 0.040 |
Why?
|
| Reference Values | 1 | 2018 | 200 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 115 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 402 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 631 | 0.030 |
Why?
|
| Quality of Life | 1 | 2022 | 521 | 0.030 |
Why?
|
| Sequence Homology | 1 | 2017 | 10 | 0.030 |
Why?
|
| Queensland | 1 | 2017 | 7 | 0.030 |
Why?
|
| Islands | 1 | 2017 | 7 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2022 | 841 | 0.030 |
Why?
|
| Sequestosome-1 Protein | 1 | 2017 | 2 | 0.030 |
Why?
|
| Autophagosomes | 1 | 2017 | 5 | 0.030 |
Why?
|
| Africa | 1 | 2017 | 18 | 0.030 |
Why?
|
| Whole Genome Sequencing | 1 | 2017 | 25 | 0.030 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2017 | 33 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 49 | 0.030 |
Why?
|
| Lysosomes | 1 | 2017 | 56 | 0.030 |
Why?
|
| Carboxyhemoglobin | 1 | 2016 | 3 | 0.030 |
Why?
|
| Sputum | 1 | 2016 | 8 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 1280 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2016 | 17 | 0.030 |
Why?
|
| Cough | 1 | 2016 | 11 | 0.030 |
Why?
|
| Cell-Derived Microparticles | 1 | 2016 | 11 | 0.030 |
Why?
|
| Thorax | 1 | 2016 | 29 | 0.030 |
Why?
|
| Pulmonary Alveoli | 1 | 2016 | 33 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 2016 | 47 | 0.030 |
Why?
|
| Cotinine | 1 | 2016 | 46 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 377 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2015 | 46 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2015 | 31 | 0.030 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 72 | 0.030 |
Why?
|
| Nicotine | 1 | 2016 | 86 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 131 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2015 | 123 | 0.030 |
Why?
|
| Axoneme | 1 | 2014 | 1 | 0.030 |
Why?
|
| Mucociliary Clearance | 1 | 2014 | 3 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2015 | 222 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 380 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 4802 | 0.030 |
Why?
|
| Microtubules | 1 | 2014 | 90 | 0.030 |
Why?
|
| Glycosaminoglycans | 1 | 2014 | 55 | 0.030 |
Why?
|
| Histone Deacetylases | 1 | 2014 | 26 | 0.030 |
Why?
|
| Arteries | 1 | 2014 | 66 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 36 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2015 | 463 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 123 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2016 | 481 | 0.030 |
Why?
|
| Regulatory Factor X Transcription Factors | 1 | 2013 | 3 | 0.030 |
Why?
|
| Transcription Initiation Site | 1 | 2013 | 9 | 0.030 |
Why?
|
| Weight Gain | 1 | 2014 | 76 | 0.030 |
Why?
|
| Adipocytes | 1 | 2014 | 59 | 0.030 |
Why?
|
| Beak | 1 | 2013 | 1 | 0.020 |
Why?
|
| Feathers | 1 | 2013 | 3 | 0.020 |
Why?
|
| Poland | 1 | 2013 | 7 | 0.020 |
Why?
|
| Breeding | 1 | 2013 | 11 | 0.020 |
Why?
|
| Diet, High-Fat | 1 | 2014 | 144 | 0.020 |
Why?
|
| Animal Husbandry | 1 | 2013 | 10 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 1032 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 404 | 0.020 |
Why?
|
| Europe | 1 | 2013 | 99 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2013 | 270 | 0.020 |
Why?
|
| Tonga | 1 | 2012 | 1 | 0.020 |
Why?
|
| Musa | 1 | 2012 | 2 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 119 | 0.020 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2012 | 133 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 257 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2012 | 166 | 0.020 |
Why?
|
| Lung Neoplasms | 1 | 2014 | 360 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2010 | 40 | 0.020 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2009 | 1 | 0.020 |
Why?
|
| Genetic Complementation Test | 1 | 2009 | 24 | 0.020 |
Why?
|
| Interferon-alpha | 1 | 2009 | 50 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 2426 | 0.020 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2009 | 51 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2010 | 109 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2014 | 1507 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 196 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2009 | 249 | 0.020 |
Why?
|
| Codon, Initiator | 1 | 2005 | 6 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2005 | 4 | 0.010 |
Why?
|
| Binding Sites | 1 | 2005 | 355 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 612 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 314 | 0.010 |
Why?
|